Analyst: Subdued prognosis from Sonova after non-renewal of contract

During the fiscal year 2022/23, Sonova lost a significant client in the US as their contract was not renewed. The prognosis for the coming year will be affected as such, estimates Sydbank analyst
by marketwire, translated by christian radich hoffman

Compared to its Danish hearing aid rivals of Demant and GN, Swiss Sonova reports of a toned-down prognosis for the coming fiscal year.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading